Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
40,736,075
-
Share change
-
+741,298
-
Total reported value
-
$1,592,413,587
-
Put/Call ratio
-
342%
-
Price per share
-
$39.10
-
Number of holders
-
148
-
Value change
-
+$27,611,475
-
Number of buys
-
79
-
Number of sells
-
53
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q1 2018
As of 31 Mar 2018,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,736,075 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Novo Holdings A/S, PERCEPTIVE ADVISORS LLC, STATE STREET CORP, FARALLON CAPITAL MANAGEMENT LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, and EAGLE ASSET MANAGEMENT INC.
This page lists
148
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.